Answers are grounded in this paper and cite their sources.
Assesses the biocompatibility and structural properties of hydroxyapatite nanoparticles, suggesting their potential in biomedical applications.
Hydroxyapatite nanoparticles (HANPs) were synthesized by the hydrothermal method and carefully characterized to assess their potential as biomaterials. XRD and SEM analyses determined that the synthesized particles were phase-pure hydroxyapatite with a hexagonal structure. Calcination enhanced the crystallinity of the nanoparticles but did not significantly change their average size (≈25 nm). While EDX verified the presence of Ca, P, and O with a Ca/P ratio near stoichiometric hydroxyapatite, SEM images revealed densely packed, rough-surfaced nanoparticles. The HANPs showed promising biological activity in several assays. Antifungal testing showed a 20 ± 0.7 mm inhibition zone against C. albicans . Antibacterial studies revealed inhibition zones against Bacillus subtilis , Escherichia coli , Pseudomonas aeruginosa , and Staphylococcus aureus ranged from 18 to 23 mm. The observed low hemolytic responses indicated excellent blood compatibility of HANPs. Antioxidant and anti-inflammatory assays demonstrated concentration-dependent inhibition, with higher activity observed as the concentration increased. Overall, HANPs exhibited enhanced crystallinity and good structural purity. They showed strong antimicrobial activity, low hemolysis, and promising antioxidant and anti-inflammatory responses. Thus, they demonstrated their potential as a promising biomaterial.
No takes yet. Share an insight, caveat, or question.
Chavan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: